Initial Statement of Beneficial Ownership (3)
December 31 2020 - 4:14PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Eagan Ewell Patrick |
2. Date of Event Requiring Statement (MM/DD/YYYY)
12/31/2020
|
3. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC. [VMD]
|
(Last)
(First)
(Middle)
625 E. KALISTE SALOOM RD. |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner ___X___ Officer (give title below) _____ Other (specify below) General Counsel / |
(Street)
LAFAYETTE, LA 70508
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Stock Options | (1) | 11/4/2030 | Common Shares | 36554.0 | $8.55 | D | |
Explanation of Responses: |
(1) | Options granted to reporting person on November 4, 2020, which vest in three equal installments beginning on the first anniversary of the grant date. |
Remarks: As the Company no longer qualifies as a foreign private issuer, effective January 1, 2021, the Company's officers, directors, and principal shareholders are subject to Section 16 of the Securities Exchange Act of 1934 ("Exchange Act"). Previously, the Company has determined that it qualified as a foreign private issuer under the Exchange Act and has made use of the foreign private issuer accommodations under U.S. securities laws. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Eagan Ewell Patrick 625 E. KALISTE SALOOM RD. LAFAYETTE, LA 70508 |
|
| General Counsel |
|
Signatures
|
/s/ Ewell Patrick Eagan | | 12/31/2020 |
**Signature of Reporting Person | Date |
VieMed Healthcare (NASDAQ:VMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
VieMed Healthcare (NASDAQ:VMD)
Historical Stock Chart
From Apr 2023 to Apr 2024